| | Hang Seng Index | 26.060 HKD | -0.460 | -1.735% | 504.32M | 13.18B | 26.532 (-1.779%) HKD as at 2025/11/17 | | |
| | Hang Seng TECH Index | 5.530 HKD | -0.120 | -2.124% | 1.38B | 7.68B | 5.643 (-2.009%) HKD as at 2025/11/17 | | |
| | Hang Seng China Enterprises Index | 93.520 HKD | -1.920 | -2.012% | 32.36M | 3.04B | 96.009 (-2.592%) HKD as at 2025/11/14 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng TECH Index | 5.440 HKD | -0.235 | -4.141% | 279.90M | 1.54B | 5.680 (-4.224%) HKD as at 2025/11/17 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng TECH Index | 1.400 HKD | +0.054 | +4.012% | 502.90M | 699.06M | 1.347 (+3.942%) HKD as at 2025/11/17 | | |
| | | 10.700 HKD | -0.110 | -1.018% | 47.29M | 506.37M | 10.818 (-1.087%) HKD as at 2025/11/14 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | SK hynix Inc. | 13.180 HKD | -1.630 | -11.006% | 32.37M | 432.39M | 14.872 (-11.375%) HKD as at 2025/11/17 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 1.820 HKD | +0.066 | +3.763% | 225.31M | 407.04M | 1.758 (+3.509%) HKD as at 2025/11/17 | | |
| | Hang Seng TECH Index (net total return version) | 11.900 HKD | -0.240 | -1.977% | 33.21M | 396.27M | 12.251 (-2.867%) HKD as at 2025/11/14 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng Index | 6.025 HKD | -0.220 | -3.523% | 61.30M | 371.58M | 6.245 (-3.523%) HKD as at 2025/11/17 | | |
| | Hang Seng High Dividend 30 Index (price return version) | 19.890 HKD | -0.430 | -2.116% | 13.02M | 259.66M | 20.337 (-2.200%) HKD as at 2025/11/14 | | |
| | Hang Seng TECH Index | 5.625 HKD | -0.110 | -1.918% | 42.18M | 238.05M | 5.791 (-2.863%) HKD as at 2025/11/14 | | |
| | HSI ESG Enhanced Index | 54.140 HKD | -0.860 | -1.564% | 3.80M | 205.74M | 55.106 (-1.753%) HKD as at 2025/11/17 | | |
| | | 9.360 HKD | -0.155 | -1.629% | 19.32M | 181.27M | 9.567 (-2.162%) HKD as at 2025/11/14 | | |
| | MSCI All Country Asia ex Japan Index | 69.120 HKD | -1.480 | -2.096% | 2.17M | 150.35M | 70.208 (-1.549%) HKD as at 2025/11/14 | | |
| | MSCI Japan 100% Hedged to USD Index | 25.200 HKD | -0.820 | -3.151% | 5.86M | 148.46M | 26.144 (-3.611%) HKD as at 2025/11/14 | | |
| | London Gold Fixing Price | 2,874.000 HKD | -48.000 | -1.643% | 40.39K | 116.16M | 386.000 (-4.360%) USD as at 2025/11/13 | | |
| | CSI 300 Index | 51.820 HKD | -0.260 | -0.499% | 2.23M | 115.43M | 52.127 (-0.589%) HKD as at 2025/11/17 | | |
| | FTSE China A50 Index | 15.880 HKD | -0.060 | -0.376% | 6.23M | 99.02M | 16.115 (-1.456%) HKD as at 2025/11/14 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 3.420 HKD | +0.164 | +5.037% | 16.12M | 54.74M | 3.311 (+3.292%) HKD as at 2025/11/14 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Solactive Gold 1-Day Rolling Futures Index | 23.100 HKD | -0.780 | -3.266% | 2.36M | 54.43M | 23.915 (-3.407%) HKD as at 2025/11/14 | | |
| | Hang Seng Index | 23.800 CNY | -0.420 | -1.734% | 1.25M | 29.87M | 24.259 (-1.892%) CNY as at 2025/11/17 | | |
| | CSI Hong Kong Dividend Index | 39.300 HKD | -0.780 | -1.946% | 629.85K | 24.86M | 40.304 (-2.492%) HKD as at 2025/11/17 | | |
| | FTSE China A50 Index | 15.090 HKD | -0.070 | -0.462% | 1.51M | 22.80M | 15.186 (-0.635%) HKD as at 2025/11/17 | | |
| | | 29.700 HKD | -1.620 | -5.172% | 729.60K | 21.71M | 30.906 (-3.903%) HKD as at 2025/11/14 | | |
| | Hang Seng High Dividend Yield Index | 30.720 HKD | -0.580 | -1.853% | 701.34K | 21.59M | 31.394 (-2.148%) HKD as at 2025/11/14 | | |
| | Hang Seng Biotech Index | 15.900 HKD | -0.220 | -1.365% | 1.35M | 21.51M | 16.168 (-1.659%) HKD as at 2025/11/17 | | |
| | | 1,109.250 HKD | +0.250 | +0.023% | 17.88K | 19.84M | 1,108.701 (+0.050%) HKD as at 2025/11/17 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Nikkei Stock Average | 32.720 HKD | +2.160 | +7.068% | 575.72K | 18.47M | 30.672 (+6.676%) HKD as at 2025/11/17 | | |
| | CME CF Bitcoin Reference Rate - Asia Pacific Variant | 11.020 HKD | -0.650 | -5.570% | 1.62M | 18.00M | 11.641 (-5.332%) HKD as at 2025/11/17 | | |